Christopher H. Price
Direktor/Vorstandsmitglied bei Otothera Corp.
Profil
Christopher H.
Price is a Director of AudioFusion, Inc. He is a Leader of Pharmaceuticals and Biotechnology for Liquidia Technologies, Inc. He is a Director of Otothera, Inc. He is a Member of the Scientific and Clinical Advisory Board of The Endpoint Group and ConjuGate, Inc. He is Chief Executive Officer of LAAMScience, Inc. Prior to joining LAAMScience, Dr. Price founded Larex, Inc. and served as President and Chief Executive Officer.
Before Larex, Dr. Price was a Principal of Medical Innovation Partners.
Previously, he was President and Chief Executive Officer of Nobex Corp.
He began his business career at Nova Pharmaceutical Corp.
as Vice President of Business Development.
He has more than 20 years of senior executive R&D, business development, and management experience in biotechnology, pharmaceuticals, medical devices, and specialty chemicals.
Dr. Price received a PhD in Biology from Syracuse University and an MBA from the Massachusetts Institute of Technology.
Aktive Positionen von Christopher H. Price
| Unternehmen | Position | Beginn |
|---|---|---|
Otothera Corp.
 Otothera Corp. Medical SpecialtiesHealth Technology Otothera Corp. manufactures therapeutic devices for the management and treatment of tinnitus. It offers hearing aid-like devices and non-wearable devices such as table-top sound machines and whirring fan. The company was founded in 2005 and is located in Winston-Salem, NC. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher H. Price
| Unternehmen | Position | Ende |
|---|---|---|
| Nova Pharmaceutical Corp. | Corporate Officer/Principal | - |
Larex, Inc.
 Larex, Inc. Food RetailRetail Trade Larex, Inc. supplies nutritional food compounds. The company was founded in 1987 and is headquartered in White Bear Lake, MN. | Präsident | - |
LAAMScience, Inc.
 LAAMScience, Inc. Industrial SpecialtiesProcess Industries LaamScience, Inc. developed specialized coatings. The company was founded by Thomas H. Roberg and headquartered in Raleigh, NC. | Vorstandsvorsitzender | - |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | - |
Nobex Corp.
 Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Präsident | - |
Ausbildung von Christopher H. Price
| Massachusetts Institute of Technology | Masters Business Admin |
| Syracuse University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
LAAMScience, Inc.
LAAMScience, Inc. Industrial SpecialtiesProcess Industries LaamScience, Inc. developed specialized coatings. The company was founded by Thomas H. Roberg and headquartered in Raleigh, NC. | Process Industries |
Otothera Corp.
Otothera Corp. Medical SpecialtiesHealth Technology Otothera Corp. manufactures therapeutic devices for the management and treatment of tinnitus. It offers hearing aid-like devices and non-wearable devices such as table-top sound machines and whirring fan. The company was founded in 2005 and is located in Winston-Salem, NC. | Health Technology |
Nobex Corp.
Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Health Technology |
Larex, Inc.
Larex, Inc. Food RetailRetail Trade Larex, Inc. supplies nutritional food compounds. The company was founded in 1987 and is headquartered in White Bear Lake, MN. | Retail Trade |
| Nova Pharmaceutical Corp. |
